Clinical trial
ELMAR - Elimination of Microemboli During Aortic Valve Replacement. A Randomized Controlled Trial
NCT01128751 is registered in ClinicalTrials.gov with University of Giessen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ELMAR - Elimination of Microemboli During Aortic Valve Replacement. A Randomized Controlled Trial
- Lead sponsor
- University of Giessen
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2010
- Completion date
- Not reported
- Enrollment
- 150 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
neurocognitive outcome after aortic valve replacement